Next, we assessed T‐cell‐dependent cellular cytotoxicity (TDCC) and found that TriTNE enabled T‐cell‐specific tumor cell killing and that TDCC increased as the effector cell (CD8+ T cell):target cell (4T1) ratio (E/T ratio) increased (Figure 2J). Here, CD8A is linked to neoplasm.